Dashenlin Pharmaceutical Group Co., Ltd. logo

Dashenlin Pharmaceutical Group Co., Ltd. (603233)

Market Open
10 Aug, 06:57
SSE SSE
¥
18. 23
+0.72
+4.1119%
¥
16.64B Market Cap
- P/E Ratio
1.24% Div Yield
11.9M Volume
- Eps
¥ 17.51
Previous Close
Add Transaction
Day Range
17.42 18.51
Year Range
14.39 21.78
Want to track 603233 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

603233 trading today higher at ¥18.23, an increase of 4.1119% from yesterday's close, completing a monthly increase of 20.6486% or ¥3.12. Over the past 12 months, 603233 stock gained 3.6384%.
603233 pays dividends to its shareholders, with the most recent payment made on Jun 26, 2026. The next estimated payment will be in In 4 months on Dec 26, 2026 for a total of ¥0.49.
The last earnings report, released on Apr 24, 2026, missed the consensus estimates by -0.0815%. On average, the company has surpassed earnings expectations by 0.0162%, based on the last three reports.
Dashenlin Pharmaceutical Group Co., Ltd. has completed 5 stock splits, with the recent split occurring on Jun 09, 2023.
The company's stock is traded on one exchange.

603233 Chart

People also search for

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
¥ 140.8
+0.7369%
Shanghai United Imaging Healthcare Co., Ltd.
¥ 112.74
+0.0355%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
¥ 30.71
+0.8207%
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. A Shares
¥ 140
+2.1898%
Beijing Tiantan Biological Products Co., Ltd.
¥ 12.85
+0.5477%

Dashenlin Pharmaceutical Group Co., Ltd. (603233) FAQ

What is the stock price today?

The current price is ¥18.23.

On which exchange is it traded?

Dashenlin Pharmaceutical Group Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 603233.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.24%.

What is its market cap?

As of today, the market cap is 16.64B.

Has Dashenlin Pharmaceutical Group Co., Ltd. ever had a stock split?

Dashenlin Pharmaceutical Group Co., Ltd. had 5 splits and the recent split was on Jun 09, 2023.

Dashenlin Pharmaceutical Group Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Guoqiang Ke CEO
SSE Exchange
CNE100002RG2 ISIN
CN Country
45,466 Employees
26 Jun 2026 Last Dividend
9 Jun 2023 Last Split
- IPO Date

Overview

DaShenLin Pharmaceutical Group Co., Ltd. is a comprehensive entity in the pharmaceutical industry within China, focusing on the manufacturing, wholesale, and retail sectors. Since its establishment in 1999, the company has developed a solid foundation in its field, operating out of Guangzhou, China. Its business encompasses a broad spectrum of pharmaceutical products, catering to various healthcare needs through both traditional Chinese and modern Western medicine approaches.

Products and Services

  • Chinese and Western Patent Medicines:

    DaShenLin offers a variety of patented pharmaceutical products that include both traditional Chinese medicines and Western-style drugs. By providing an array of treatments, they cater to a wide range of medical conditions, ensuring access to quality healthcare solutions.

  • Ginseng Tonic Medicinal Materials and Chinese Herbal Pieces:

    This line of products emphasizes the importance of traditional Chinese medicinal practices, offering high-quality ginseng tonics and a selection of herbal pieces. These are key ingredients for many traditional treatments, known for their health benefits and healing properties.

  • Health Care Products:

    The company extends its offerings to include health care products aimed at enhancing general well-being and preventing illnesses. These products are designed to meet the wellness needs of the modern consumer, promoting a healthy lifestyle.

  • Medical Equipment:

    DaShenLin provides a range of medical equipment, supporting healthcare facilities and professionals in delivering medical services. This category includes items essential for diagnosis, treatment, and patient care, ensuring the availability of high-quality medical apparatus.

  • Other Commodities:

    Expanding beyond the pharmaceutical and medical sectors, the company also offers a selection of other commodities. This diversity reflects DaShenLin’s commitment to catering to the broader needs of their customers, providing more than just healthcare products.

Contact Information

Address: No. 410-1, Longxi Avenue, Guangzhou, China, 51000
Phone: 86 20 8128 4688